Uncategorized

"A drug that was never meant for kids was illegally marketed to kids," said a lawyer for the plaintiff in opening remarks for the...

An Op-Ed in Op-Ed News discusses the disconnect between concern about rising suicide rates in the general population (and the military) and awareness of...

What follows is my attempt to report on the Pre-Seminar program from the 17th International Conference on the Treatment of Psychosis.

1 Boring Old Man reflects on his work with children and adolescents, in which he directly observes the troubling effects of antidepressants, and the...

Thomas Szasz, relentless "critic of coercive psychiatry, the 'therapeutic state,' and the war on drugs," died at his home in Manlius, N.Y. over the...

In an interview with Pharmalot, former FDA associate chief counsel Arnie Friede discusses the impact of last month's $181 million Risperdal settlement on pharmaceuticals'...

I just learned that Dr. Martin Keller, principal investigator of the controversial Paxil study 329, has retired from his position as a professor of...

I have just attended the 17th International Conference on the Treatment of Psychosis in Tornio, Finland. I am full of thoughts and I keep trying to figure out how I will explain this meeting to others.

Beyond Prozac: Author, teacher, and mental health coach Douglas Bloch writes on using holistic tools and coping strategies to manage the symptoms of depression, anxiety...

1 Boring Old Man bores ever more deeply into the newly available raw data from GlaxoSmithKline's study of Paxil in children, finding that "if...

Brothers and sisters, I want to tell you a little movement history which I am sure many of you don't know.

ProPublica offers an interactive tool that lets you search nursing home inspection reports for problems such as antipsychotic overprescribing.

Pharmalot writes of a Paxil study which has been discredited for a decade, but never retracted or nor its authors rebuked despite the wide-ranging...

Recent Review of Environmental Risk Factors for Schizophrenia from Fuller Seminary on Vimeo. Recent Review of Environmental Risk Factors for Schizophrenia From the 2012 Symposium...

An international team of researchers (including Irving Kirsch) found in a review "of 62 pivotal antidepressant trials consisting of data from 13,802 depressed patients"...

Researchers from Harvard and the University of Melbourne identified physicians and scientists who had financial relationships with pharmaceutical companies named as defendants in U.S....

Time magazine reviews the evidence on exercise for depression, finding that exercise alters brain chemistry such that the brain shows less stress in response...

Three former executives from Purdue Pharma have been barred by a federal appeals court from doing business with federal healthcare programs such as Medicare...

As the schizophrenia/psychosis recovery research continues to emerge, we discover increasing evidence that psychosis is not caused by a disease of the brain, but...

Attorney Jamie Sheller of Philadelphia firm Sheller, P.C. discusses a client whose child had birth defects caused by taking Paxil during her pregnancy. GlaxoSmithKline...

Almost 50 million prescriptions for antidepressants were issued in the U.K. in 2011, a rise of 9% over 2010. The increase is attributed, at...

Consumer Reports recommends against antipsychotic "augmentation therapy" for depression. The consumer watchdog magazine finds that the unproven efficacy, harmful side effects, availability of alternatives,...

The August issue of the British Journal of Psychiatry offers an editorial stating that, as "mental health services appear to have overestimated the strength...

David Weinberg writes in Science-Based Medicine that implausible theories must be held to a higher standard of proof in evidence-based research. In a review...